Results 1 to 10 of about 48,234 (169)

The cost of entry: An analysis of pharmaceutical registration fees in low-, middle-, and high-income countries. [PDF]

PLoS ONE, 2017
Advances in pharmaceuticals offer improved health outcomes for a wide range of illnesses, yet medicines are often inaccessible for many patients worldwide.
Steven G Morgan, Brandon Yau, Murray M Lumpkin   +2 more
doaj   +4 more sources

Effect of free trade agreements on pharmaceutical market competition: The case of the 2009 US-Peru free trade agreement and its implementation as national drug policy

Health Policy Open, 2021
Free Trade Agreements (FTA) are controversial for threatening essential aspects of health, especially access to affordable medicines. The US-Peru FTA required changes in the Peruvian pharmaceutical legislation that resulted in the implementation of the ...
Lita Araujo, Enrique Seoane-Vazquez, Michael Montagne   +2 more
doaj   +1 more source

The impact of the increase in import verification fees on local production capacity of selected medicines in Uganda

Journal of Pharmaceutical Policy and Practice, 2023
Background The local manufacture of pharmaceuticals is an opportunity to develop a broader manufacturing and knowledge-based economy and reduce over dependence on imports.
Kalidi Rajab, Solomon Onen, Diana Kesi Nakitto, Allan Serwanga, Joseph Mutasaaga, Leonard Manirakiza, Denis Mwesigwa, David Nahamya, Helen Byomire Ndagije   +8 more
doaj   +1 more source

Just Rules for Innovative Pharmaceuticals

Philosophies, 2022
Globalized in 1995 through the TRIPs Agreement, humanity’s dominant mechanism for encouraging innovations involves 20-year product patents, whose monopoly features enable innovators to reap large markups or licensing fees from early users.
Thomas Pogge
doaj   +1 more source

The Role of Taxing Financial-Economic Performance on Companies in the Pharmaceutical Sector [PDF]

Annals of Dunarea de Jos University. Fascicle I : Economics and Applied Informatics, 2020
In order to determine the impact taxation has on the financial-economic performances, we must strongly consider the determination relations of the financial performance indexes based on the profit and loss account.
Mihaela Cristina ONICA
doaj   +1 more source

Reducing abnormal expenses in national health insurance based on a control chart and decision tree-driven define, measure, analyze, improve and control process

Health Informatics Journal, 2023
This study examined the cost of medical insurance for “sepsis” treatment in Taiwan. We applied statistical tests, cost control charts, and C5.0 decision trees using the define, measure, analyze, improve and control (DMAIC) process to mine data on ...
Yen-Chang Chen, Shui-Chuan Chen, Ying-Sing Liu   +2 more
doaj   +1 more source

Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy

Frontiers in Public Health, 2023
To implement state policies of zero-markup drug policy and medical service fee adjustment for public hospitals, this study constructed game models of the pharmaceutical supply chain, consisting of a drug supplier and a public hospital. The study obtained
Nan Zhou, Shiyang Li, Gang Zhao, Chengjiang Li, Chengjiang Li, Na Yu   +5 more
doaj   +1 more source

Discrepancies in Open Access Fees within Pharmacology, Toxicology, and Pharmaceutics Journals

Advanced Pharmaceutical Bulletin, 2023
Modern science has been transformed by open access (OA) publishing levied a significant economic burden on the authors. This article analyzes the discrepancies among OA publication fees in pharmacology, toxicology, and pharmaceutics. The observations comprise 160 OA journals and their corresponding Q ranking, SJR, H index, impact factor, country, and ...
Rana M.F. Sammour, Aliasgar Shahiwala
openaire   +3 more sources

A systematic review of pharmaceutical price mark-up practice and its implementation

Exploratory Research in Clinical and Social Pharmacy, 2021
Pharmaceutical products, apart from being essential for medical treatment, are of high value and heavily regulated to ensure the prices are controlled.
Kah Seng Lee, Yaman Walid Kassab, Nur Akmar Taha, Zainol Akbar Zainal   +3 more
doaj   +1 more source

Study of Ukrainian price market of medicines for scalp seborrheic dermatitis treatment

Aktualʹnì Pitannâ Farmacevtičnoï ì Medičnoï Nauki ta Praktiki, 2018
Considering mostly long time use of medicines by the patients with scalp seborrheic dermatitis (SSD) the social-economical availability of medications with antiseborrheic activity becomes important and the price of medicine appear as a certain measure.
V. А. Solodovnyk, N. О. Tkachenko, S. А. Gladysheva   +2 more
doaj   +1 more source